BACKGROUND: Cancer cell growth has been described to depend on glucose utilization. Activation of Akt and up-regulation of pyruvate kinase M2 (M2-PK) are attributes of tumour glycolysis. PATIENTS AND METHODS: In order to evaluate the prognostic relevance of glycolytic markers in breast cancer, the expression of pAkt and M2PK was analysed in 160 tissue samples. The staining results were compared with clinicopathological characteristics and survival data. RESULTS: Overexpression of pAkt was detected in 58% and of M2PK in 70% of breast cancer samples. Increased pAkt-expression was accompanied with shorter survival time. In contrast, M2PK expression was significantly higher in patients surviving breast cancer for more than 13 years. CONCLUSION: Strong M2PK expression seems to be a favourable prognostic factor and its role in breast cancer progression should be further explored. Our data confirm previous observations of pAkt as a negative prognostic marker.
BACKGROUND:Cancer cell growth has been described to depend on glucose utilization. Activation of Akt and up-regulation of pyruvate kinase M2 (M2-PK) are attributes of tumour glycolysis. PATIENTS AND METHODS: In order to evaluate the prognostic relevance of glycolytic markers in breast cancer, the expression of pAkt and M2PK was analysed in 160 tissue samples. The staining results were compared with clinicopathological characteristics and survival data. RESULTS: Overexpression of pAkt was detected in 58% and of M2PK in 70% of breast cancer samples. Increased pAkt-expression was accompanied with shorter survival time. In contrast, M2PK expression was significantly higher in patients surviving breast cancer for more than 13 years. CONCLUSION: Strong M2PK expression seems to be a favourable prognostic factor and its role in breast cancer progression should be further explored. Our data confirm previous observations of pAkt as a negative prognostic marker.
Authors: Jennifer A Wittwer; Delira Robbins; Fei Wang; Sarah Codarin; Xinggui Shen; Christopher G Kevil; Ting-Ting Huang; Holly Van Remmen; Arlan Richardson; Yunfeng Zhao Journal: Cancer Prev Res (Phila) Date: 2011-06-14
Authors: Barbara Chiavarina; Diana Whitaker-Menezes; Ubaldo E Martinez-Outschoorn; Agnieszka K Witkiewicz; Ruth Birbe; Anthony Howell; Richard G Pestell; Johanna Smith; Rene Daniel; Federica Sotgia; Michael P Lisanti Journal: Cancer Biol Ther Date: 2011-12-15 Impact factor: 4.742
Authors: Daniel Fatela-Cantillo; Antonio Fernandez-Suarez; Miguel Alonso Marin Moreno; Juan Jesus Puente Gutierrez; Jose Miguel Diaz Iglesias Journal: Tumour Biol Date: 2012-01-10
Authors: Jun Chen; Evan LaGue; Junjie Li; Chendong Yang; Edward P Hackett; Manuel Mendoza; Jeffry R Alger; Ralph J DeBerardinis; Ian R Corbin; Kelvin L Billingsley; Jae Mo Park Journal: Anal Sens Date: 2021-09-14
Authors: J R Dev Arundhathi; Sandeep R Mathur; Ajay Gogia; S V S Deo; Purusottam Mohapatra; Chandra Prakash Prasad Journal: Mol Biol Rep Date: 2021-05-28 Impact factor: 2.316